Ausmedicann Pty Ltd (trading as The People’s Plant)

Ausmedicann, trading as The People’s Plant, is pioneering sustainable outdoor-hybrid medicinal cannabis cultivation in Australia. With a community of over 1,400 investors already backing its vision through successful crowdfunding raises, Ausmedicann is now ready to commercialise its hard-earned R&D to become the largest hybrid cultivation and processing
facilities in the country. Leveraging regenerative agriculture, renewable energy, and gold-standard solventless extraction, Ausmedicann is positioned to meet the surging demand for affordable, high-quality medicinal cannabis. Funds from this raise will complete facility build-out, establish commercial size post-harvest capabilities, and accelerate market entry. Business has progressed significantly with ~$4.5 million invested over 6 years of research & development. The business has already secured offtake agreements with a key future client partners and presents an exciting opportunity for investors to support the final phase of establishment through to commercialisation.